Werewolf Therapeutics HOWL
NASDAQ HOWL
$0.99 +0.02 (+1.95%)
At close: Nov 11, 2026 · 4:00 PM EST

Werewolf Therapeutics (HOWL) Current Deferred Revenue (2022 - 2024)

Updated

Werewolf Therapeutics' Current Deferred Revenue came in at $502,000 for Q1 2024, down 44.7% from the prior quarter.

Analysis

Werewolf Therapeutics (HOWL) Current Deferred Revenue (2022 - 2024) Analysis & Trends

At the end of FY2023, Werewolf Therapeutics' Current Deferred Revenue was $907,000, down 86.1% from FY2022.

  • Going back by year, Current Deferred Revenue was $6.53 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Werewolf Therapeutics 47.14 Mn -144.12 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 502,000.00
Dec 31, 2023 907,000.00
Sep 30, 2023 1.81 Mn
Dec 31, 2022 6.53 Mn
API Access

Werewolf Therapeutics Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=HOWL&period=max&api_key=YOUR_API_KEY